HealthcareServices

Calciphylaxis Market Forecast: What to Expect by 2029

November 27, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Calciphylaxis Market By 2029?

The calciphylaxis market has experienced significant growth in recent years. It is projected to expand from $3.22 billion in 2024 to $3.54 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.7%. The historical growth of this market can be attributed to the rising prevalence of chronic kidney disease, increasing awareness of rare diseases, greater government support for rare disease research, the development of favorable regulatory environments, and increasing healthcare expenditure.

The calciphylaxis market is projected to experience substantial expansion in the coming years, anticipated to reach $5.09 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.5%. Factors contributing to this growth during the forecast period include an expanding global elderly population, new therapeutic advancements, wider availability of dialysis in developing areas, increased funding for rare disease drug development, and a higher occurrence of end-stage renal disease. Key trends expected within this period encompass improvements in dialysis and kidney care, the creation of treatments for mineral and bone disorders, progress in personalized medicine, biotech advancements, new therapeutic approaches, and developments in healthcare policies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21124&type=smp

What Are The Main Drivers Boosting The Calciphylaxis Industry’s Expansion?

The increasing occurrence of chronic kidney disease (CKD) is anticipated to drive the expansion of the calciphylaxis market in the future. CKD refers to a progressive, long-standing ailment where the kidneys gradually lose their capacity to remove waste products and surplus fluids from the bloodstream, potentially resulting in kidney failure eventually. This surge in CKD cases is linked to an older demographic, a growing number of individuals with diabetes and high blood pressure, poor lifestyle habits, and insufficient early diagnosis and treatment of kidney issues. Calciphylaxis acts as a crucial sign of severe blood vessel problems in CKD, underscoring the importance of prompt action and better handling of mineral imbalances to prevent tissue death and related health complications. For example, data from December 2024, provided by the Australian Institute of Health and Welfare, an Australia-based government agency, revealed a steady rise in chronic kidney disease (CKD) mortality rates between 2021 and 2022, with increases of 4.2% in 2021 and 6.2% in 2022, indicating faster growth in the later year. Consequently, the increasing prevalence of chronic kidney disease (CKD) is stimulating the expansion of the calciphylaxis market.

What Are The Segment Types Shaping The Calciphylaxis Market?

The calciphylaxismarket covered in this report is segmented –

1) By Type: Non-Uremic Calciphylaxis; Ulcers And Wounds; Debridement Of Wounds

2) By Treatment: Drug Therapy; Hyperbaric Calciphylaxis Therapy

3) By Diagnosis: Deep Skin Biopsies; Blood Tests; Imaging

4) By End-Use: Hospital And Clinics; Homecare; Ambulatory Centers

Subsegments:

1) By Non-Uremic Calciphylaxis: Vascular Calcification; Soft Tissue Calcification; Cutaneous Manifestations

2) By Ulcers and Wounds: Skin Ulcers; Ischemic Wounds; Necrotic Ulcers; Pressure Ulcers

3) By Debridement Of Wounds: Surgical Debridement; Enzymatic Debridement; Autolytic Debridement; Mechanical Debridement; Biological Debridement

Which Key Trends Are Expected To Influence The Calciphylaxis Market In The Coming Years?

Leading entities within the calciphylaxis market are prioritizing the creation of novel treatments, including enzyme replacement therapy, with the goal of enhancing patient results and lessening the condition’s impact. Enzyme replacement therapy (ERT) serves as a medical intervention designed to replenish an absent or insufficient enzyme within the body. This approach is commonly employed for unusual genetic conditions where the body is unable to synthesize a particular enzyme essential for proper cellular operation. For example, during October 2024, Inozyme Pharma Inc., a US-based biopharmaceutical firm, disclosed encouraging preliminary findings from its Phase 1 SEAPORT 1 trial of INZ-701 involving individuals with end-stage kidney disease (ESKD). The preliminary trial data underscores INZ-701’s capability to reinstate enzyme activity, which is vital for averting unusual mineralization, a significant contributor to severe rare diseases. The therapy is engineered as an enzyme replacement treatment specifically addressing ENPP1 and ABCC6 deficiencies, conditions linked to the pathological accumulation of calcium in blood vessels and various tissues.

Who Are The Primary Competitors In The Global Calciphylaxis Market?

Major companies operating in the calciphylaxis market are Baxter International Inc., Opko Health Inc., Hope Pharmaceuticals Ltd

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/calciphylaxis-global-market-report

How Does The Calciphylaxis Market Perform Across Key Geographic Regions?

North America was the largest region in the calciphylaxis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the calciphylaxis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Calciphylaxis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21124&type=smp

Browse Through More Reports Similar to the Global Calciphylaxis Market 2025, By The Business Research Company

Calciphylaxis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/calciphylaxis-treatment-global-market-report

Diabetic Kidney Disease Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Kidney Transplant Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795